Newcastle disease virus: A promising agent for tumour immunotherapy

Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter

(2010) S L Longo et al.   CANCER GENE THERAPY

Genetically engineered Newcastle disease virus for malignant melanoma therapy

(2009) D Zamarin et al.   GENE THERAPY

Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses

(2009) Dmitriy Zamarin et al.   MOLECULAR THERAPY

Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma

(2009) Jennifer Altomonte et al.   MOLECULAR THERAPY

International progress in cancer gene therapy

(2008) B A Guinn et al.   CANCER GENE THERAPY

Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes

(2008) F Pühler et al.   GENE THERAPY

Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy

(2008) Adam Vigil et al.   MOLECULAR THERAPY

Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy

(2008) Heng Zhao et al.   VIRUS RESEARCH